TLR2 mRNA and protein levels in glioma tissues were found positively associated with glioma WHO histological grades and poor clinical outcome, and its overexpression could enhance glioma cell activity and cell cycle progression [61, 62]. This evidence concerns the gene TLR2 and glioma.